钙增敏剂在心力衰竭中的临床应用专家建议

2021-05-27 中国医师协会心血管内科医师分会中华心血管病杂志（网络版）.2021.4(1):1-8.

近年来，钙增敏剂在心力衰竭治疗方面积累了较为丰富的循证医学证据，为进一步规范和指导钙增敏剂在心力衰竭治疗中的合理应用，中国医师协会心血管内科医师分会心力衰竭学组与苏州工业园区心血管健康研究院共同发起，

中文标题：

钙增敏剂在心力衰竭中的临床应用专家建议

发布机构：

中国医师协会心血管内科医师分会

发布日期：

2021-05-27

简要介绍：

近年来，钙增敏剂在心力衰竭治疗方面积累了较为丰富的循证医学证据，为进一步规范和指导钙增敏剂在心力衰竭治疗中的合理应用，中国医师协会心血管内科医师分会心力衰竭学组与苏州工业园区心血管健康研究院共同发起，结合国内外循证医学证据以及国内临床实践经验，共同制订“钙增敏剂在心力衰竭中的临床应用专家建议”。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=add441c002115113, title=钙增敏剂在心力衰竭中的临床应用专家建议, enTitle=, guiderFrom=中华心血管病杂志（网络版）.2021.4(1):1-8., authorId=0, author=, summary=近年来，钙增敏剂在心力衰竭治疗方面积累了较为丰富的循证医学证据，为进一步规范和指导钙增敏剂在心力衰竭治疗中的合理应用，中国医师协会心血管内科医师分会心力衰竭学组与苏州工业园区心血管健康研究院共同发起，, cover=https://img.medsci.cn/2021624/1624538891724_2020535.jpg, journalId=0, articlesId=null, associationId=315, associationName=中国医师协会心血管内科医师分会, associationIntro=null, copyright=0, guiderPublishedTime=Thu May 27 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>近年来，钙增敏剂在心力衰竭治疗方面积累了较为丰富的循证医学证据，为进一步规范和指导钙增敏剂在心力衰竭治疗中的合理应用，中国医师协会心血管内科医师分会心力衰竭学组与苏州工业园区心血管健康研究院共同发起，结合国内外循证医学证据以及国内临床实践经验，共同制订“钙增敏剂在心力衰竭中的临床应用专家建议”。</p> </div> </div> </div>, tagList=[TagDto(tagId=335, tagName=心力衰竭)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=335, guiderKeyword=心力衰竭, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3536, appHits=164, showAppHits=0, pcHits=493, showPcHits=3372, likes=0, shares=44, comments=12, approvalStatus=1, publishedTime=Sat Jun 26 20:07:40 CST 2021, publishedTimeString=2021-05-27, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Jun 24 20:48:17 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 00:32:18 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=钙增敏剂在心力衰竭中的临床应用专家建议.pdf)])

钙增敏剂在心力衰竭中的临床应用专家建议.pdf

下载请点击：

评论区 (7)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1080548, encodeId=521a108054809, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 08:43:13 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065141, encodeId=88fd1065141f7, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Sat Oct 30 00:21:58 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057218, encodeId=c402105e21881, content=谢谢学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 18:33:55 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051740, encodeId=bf8f1051e4007, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=390d5607534, createdName=Miss熊, createdTime=Thu Sep 16 00:08:02 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010479, encodeId=b08e10104e962, content=在一起, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=332a2318615, createdName=yeyekeke, createdTime=Mon Aug 23 03:04:49 CST 2021, time=2021-08-23, status=1, ipAttribution=)]
2021-12-16 龙珠

学习好资料

40 0
[GetPortalCommentsPageByObjectIdResponse(id=1080548, encodeId=521a108054809, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 08:43:13 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065141, encodeId=88fd1065141f7, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Sat Oct 30 00:21:58 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057218, encodeId=c402105e21881, content=谢谢学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 18:33:55 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051740, encodeId=bf8f1051e4007, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=390d5607534, createdName=Miss熊, createdTime=Thu Sep 16 00:08:02 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010479, encodeId=b08e10104e962, content=在一起, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=332a2318615, createdName=yeyekeke, createdTime=Mon Aug 23 03:04:49 CST 2021, time=2021-08-23, status=1, ipAttribution=)]
2021-10-30 1e1366a1m07(暂无匿称)

好资料

53 0
[GetPortalCommentsPageByObjectIdResponse(id=1080548, encodeId=521a108054809, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 08:43:13 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065141, encodeId=88fd1065141f7, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Sat Oct 30 00:21:58 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057218, encodeId=c402105e21881, content=谢谢学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 18:33:55 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051740, encodeId=bf8f1051e4007, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=390d5607534, createdName=Miss熊, createdTime=Thu Sep 16 00:08:02 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010479, encodeId=b08e10104e962, content=在一起, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=332a2318615, createdName=yeyekeke, createdTime=Mon Aug 23 03:04:49 CST 2021, time=2021-08-23, status=1, ipAttribution=)]
2021-10-03 H8888888

谢谢学习了

40 0
[GetPortalCommentsPageByObjectIdResponse(id=1080548, encodeId=521a108054809, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 08:43:13 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065141, encodeId=88fd1065141f7, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Sat Oct 30 00:21:58 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057218, encodeId=c402105e21881, content=谢谢学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 18:33:55 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051740, encodeId=bf8f1051e4007, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=390d5607534, createdName=Miss熊, createdTime=Thu Sep 16 00:08:02 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010479, encodeId=b08e10104e962, content=在一起, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=332a2318615, createdName=yeyekeke, createdTime=Mon Aug 23 03:04:49 CST 2021, time=2021-08-23, status=1, ipAttribution=)]
2021-09-16 Miss熊

学习

53 0
[GetPortalCommentsPageByObjectIdResponse(id=1080548, encodeId=521a108054809, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 08:43:13 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065141, encodeId=88fd1065141f7, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Sat Oct 30 00:21:58 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057218, encodeId=c402105e21881, content=谢谢学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 18:33:55 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051740, encodeId=bf8f1051e4007, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=390d5607534, createdName=Miss熊, createdTime=Thu Sep 16 00:08:02 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010479, encodeId=b08e10104e962, content=在一起, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=332a2318615, createdName=yeyekeke, createdTime=Mon Aug 23 03:04:49 CST 2021, time=2021-08-23, status=1, ipAttribution=)]
2021-08-23 yeyekeke

在一起

73 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

心血管指南

钙增敏剂在心力衰竭中的临床应用专家建议

相关指南

拓展阅读

科室

工具

服务